J
José M. Freije
Researcher at University of Oviedo
Publications - 8
Citations - 725
José M. Freije is an academic researcher from University of Oviedo. The author has contributed to research in topics: Germline mutation & Progeria. The author has an hindex of 7, co-authored 8 publications receiving 665 citations.
Papers
More filters
Journal ArticleDOI
Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors
Claire Navarro,Juan Cadiñanos,Annachiara De Sandre-Giovannoli,Rafaëlle Bernard,Sébastien Courrier,Irène Boccaccio,Amandine Boyer,Wim J. Kleijer,Anja Wagner,Fabienne Giuliano,Frits A. Beemer,José M. Freije,Pierre Cau,Raoul C.M. Hennekam,Carlos López-Otín,Catherine Badens,Nicolas Lévy +16 more
TL;DR: RD is either a primary or a secondary laminopathy, caused by dominant de novo LMNA mutations or, more frequently, recessive null ZMPSTE24 mutations, most of which lie in a mutation hotspot within exon 9.
Journal ArticleDOI
Aging and chronic DNA damage response activate a regulatory pathway involving miR‐29 and p53
Alejandro P. Ugalde,Andrew J. Ramsay,Jorge de la Rosa,Ignacio Varela,Guillermo Mariño,Juan Cadiñanos,Jun Lu,José M. Freije,Carlos López-Otín +8 more
TL;DR: The existence of a novel regulatory circuitry involving miR‐29, Ppm1d and p53, which is activated in aging and in response to DNA damage is proposed.
Journal ArticleDOI
Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease.
TL;DR: A possible role of apolipoprotein D in progesterone transport is proposed after it was found that all the sequenced tryptic peptides from protein GCDFP-24 matched perfectly with regions present in the amino acid sequence determined for human apoliprotein D.
Journal ArticleDOI
Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain).
Pilar Blay,Íñigo Santamaría,Ana S. Pitiot,M. Luque,Marta G. Alvarado,Ana Lastra,Yolanda Fernández,Ángeles Paredes,José M. Freije,Milagros Balbín +9 more
TL;DR: The findings may help design a first step recurrent mutation panel for screening high-risk breast and/or ovarian cancer families from this specific area, which largely differ from other areas of Spain.
Journal ArticleDOI
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer
Oscar Aguilera,José Manuel González-Sancho,Sandra Zazo,Raúl Rincón,Agustín F. Fernández,Olga Tapia,Olga Tapia,Francesc Canals,Beatriz Morte,Vincenzo Calvanese,Vincenzo Calvanese,Jose L. Orgaz,Jose L. Orgaz,Núria Niell,Susana Aguilar,José M. Freije,Osvaldo Graña,David G. Pisano,Aurea Borrero,Javier Martinez-Useros,Benilde Jiménez,Mario F. Fraga,Mario F. Fraga,Jesús García-Foncillas,Carlos López-Otín,Miguel Lafarga,Federico Rojo,Alberto Muñoz +27 more
TL;DR: It is reported for the first time that a proportion of Dickkopf (DKK-1) locates within the nucleus of healthy small intestine and colon mucosa, and of CRC cells at specific chromatin sites of active transcription, which support a role of nuclear DKK- 1 as a predictive biomarker of chemoresistance in colorectal cancer.